6. Signal detection and evaluation
Based on the analysis of data collected on ARs, particularly in terms of severity, novelty and frequency, ANSM must be alerted to a potential signal that could modify the benefit/risk ratio of the drug. If the signal is confirmed, thus becoming an alert, precautionary measures and/or preventive or corrective actions must be implemented.
Signal detection in pharmacovigilance involves highlighting any potential association between a drug and the AEs it is likely to cause, where this relationship is unknown or insufficiently documented. The signal may reveal a new iatrogenic effect of the drug, but also risk factors for its occurrence, drug interactions and so on.
Signals can be detected manually, by analyzing notifications...
You do not have access to this resource.
Exclusive to subscribers. 97% yet to be discovered!
Already subscribed?
Log in!
Ongoing reading
Signal detection and evaluation